Abstract
The first 49 consecutive patients who underwent orthotopic liver transplantation between 1984 and 1989 in our department were studied with regard to symptomatic and asymptomatic post-transplantation infections. The major infections carrying a risk of fatal outcome are presented. During the first 4 weeks, fungal and bacterial infections predominated, the percentages of patients affected being 27% and 35%, respectively. Eight patients (17%) suffered from bacterial septicemia, which in six cases was due to gram-negative micro-organisms. The bacterial septicemia was often associated with severe ischemic damage to the graft, rejection, or cholangitis. In addition, a concomitant invasive fungal infection supervened in seven out of eight septic patients, further aggravating the patients' condition. Seventeen of the 49 patients (35%) died after transplantation within 3.3 years. Infection was the cause of death in nine patients (18%), with bacterial septicemia and/or fungemia in eight of these. Cytomegalovirus (CMV) disease was the dominant cause of illness after the 1st month. While only 5 of the 49 patients developed CMV disease during the 1st month (10%), as many as 16 of the 40 recipients who survived beyond that time suffered from symptomatic CMV viremia (40%). CMV mismatching, i.e., the donation of a CMV-positive organ to a CMV-seronegative recipient, entailed the highest risk for CMV disease. Pneumocystis carinii pneumonia occurred within 4 months in 10% of the patients. The four liver recipients affected were among the 20 patients not receiving trimethoprim-sulfamethoxazole prophylaxis. None of the 28 patients who received this prophylaxis over a 12-month period developed this complication (P<0.05). The time-related panorama of infectious complications observed in this study has immediate clinical implications for the screening, prophylaxis, and therapy of infections following liver transplantation.
Article PDF
Similar content being viewed by others
References
Andersson J, Ernberg I (1988) Management of Epstein-Barr virus infections. Am J Med 85 [Suppl 2A]: 107–114
Balfour HH, Chace BA, Stapleton JT (1989) A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381–1387
Barkholt LM, ericzon BG, Ehrnst A, Forsgren M, Andersson JP (1990) Cytomegalovirus infections in liver transplant patients: incidence and outcome. Transplant Proc 22: 235–237
Barkholt L, Billing H, Juliosson G, Porwit A, Ericzon BG, Groth CG (1991) B-cell lymphoma in transplanted liver-clinical, histological and radiological manifestations. Transpl Int 4: 8–11
Blumhardt G, Neuhaus P, Bechstein WO, Steffen R, Hopf U, Möller B, Raakow R, Keck H (1990) Liver transplantation in HBsAg positive patients. Transplant Proc 22: 1517–1518
Brettschneider L, Tong JL, Boose DS, Daloze PM, Smith GV, Huguet C, Blanchard H, Groth CG, Starzl TE (1968) Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg 97: 313–322
Cohen R, Roth RJ, Delgado E, Ahearn DG, Kalser MH (1969) Fungal flora of the normal human small and large intestines. N Engl J Med 280: 638–641
Dunn DL, Mayoral HL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH Jr, Fletcher CV, Bolman RM III, Matas AJ, Payne WD, Sutherland DE, Najarian JS (1991) Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 51: 98–106
Ericzon BG, Lundgren G, Wilczek H, Groth CG (1987) Experience with human liver grafts obtained after donor cardiac stand. Transplant Proc 19: 3862–3863
Ericzon BG, Eusufzai S, Kubota K, Einarsson K, Angelin B (1990) Characteristics of biliary lipid metabolism after liver transplantation. Hepatology 12: 1222–1228
Eriksson LS, Söderman C, Ericzon B-G, Eleborg L, Hedenstierna G, Wahren J (1990) Hypoxemia cured by liver transplantation. Transplant Proc 22: 172–173
George DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite RT, emond JC, Whitington PF, Broelsch CE (1991) Bacterial infections as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 13: 387–396
Grendele M, Gridelli DB, Colledan M, Rossi G, Fassati LR, Ferla G, Lunghi G, Galmarini D (1989) Hepatitis C virus and liver transplantation. Lancet II: 1221–1222
Heurlin N, Brattström C, Lönnqvist B, Westman L, Lidman C, Andersson J (1991) Aetiology of pulmonary disease in immunocompromised patients. Eur Respir J 4: 10–18
Howard TK, Klintmalm GBG, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA (1990) The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 49: 103–107
Kubota K, Ericzon BG, Barkholt L, Reinhold FP (1989) Bile cytology in orthotopic liver transplantation. Transplantation 48: 998–1003
Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter HJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W, Kuo C, Berger K, Schuster JR, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362–364
Kusne S, Dummer JS, Iwatsuki S, Singh N, Makowka L, Esquivel C, Tzakis AG, Starzl TE, Ho M (1988) Infections after liver transplantation. An analysis of 101 consecutive cases. Transplantation 67: 132–143
Laucher W, Muller R, Pichlmayr R (1987) Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 19: 2387–2389
Lautenschlager I, Höckerstedt K, Ahonen J (1988) Fine-needle aspiration biopsy in monitoring of liver allografts. II. Applications to human liver allografts. Transplantation 46: 47–52
Maddrey WC, Thiel DH van (1988) Liver transplantation: an overview. Hepatology 8: 948–959
Martin P, Munoz SJ, Di Bisceglie AM, Rubin R, Waggoner JG, Armenti VT, Moritz MJ, Jarrell BE, Maddrey WC (1991) Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 13: 719–721
Nalesnik MA, Makowka L, Starzl TE (1988) The diagnosis and treatment of post-transplant lymphoproliferative disorders. Curr Probl Surg 25: 367–472
Norder H, Brattström C, Magnius L (1989) High frequency of hepatitis B virus DNA in anti-HBe positive sera on longitudinal follow-up of patients with renal transplants and chronic hepatitis B. J Med Virol 27: 322–328
Pirsch JD, Stratta RJ, Sollinger HW, Hafez GR, D'Alessandro AM, Kalayoglu M, Belzer FO (1989) Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after organ transplantation. Am J Med 86: 241–244
Rowley A, Wolinsky SM, Sambol SP, Barkholt L, Ehrnst A, Andersson JP (1991) Rapid detection of cytomegalovirus DNA and RNA in blood of renal transplant patients by in vitro enzymatic amplification. Transplantation 51: 1028–1033
Rubin RH (1988) Infections in the renal and liver transplant patient. In: Rubin RH, Young LS (eds) Clinical approach to infections in the compromised host. 2nd edn. Plenum Press, New York, pp 603–621
Singh N, Dummer JS, Kusne S, Breinig MK, Armstrong JA, Makowka L, Starzl TE, Ho M (1988) Infections with cytomegalovirus and other herpes viruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 158: 124–131
Starzl TE, Iwatsuki S, Esquivel CO, Todo S, Kam I, Lynch S, Gordon RD, Shaw BW Jr (1985) Refinements in the surgical technique of liver transplantation. Semin Liver Dis 5: 349–356
Sundqvist VA, Wahren B (1981) An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Methods 2: 301–312
Todo S, Demetris AJ, Thiel D van, Teperman L, Fung JJ, Starzi TE (1991) Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 13: 619–629
Tollemar J, Ericzon B-G (1991) Invasive Candida albicans infection in orthotopic liver graft recipients. Incidence and risk factors. Clin Transplant 5: 306–312
Tollemar J, Ringden O, Tyden G (1990) Liposomal amphotericin-B (AmBisome) treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evaluation. Clin Transplant 4: 167–175
Tzakis AG, Gordon RD, Shaw BW Jr, Iwatsuki S, Starzl TE (1985) Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporin era. Transplantation 40: 667–671
Wajszczuk CP, Dummer JS, Ho M, Thiel DH van, Starzl TE, Iwatsuki S, Shaw BW Jr (1985) Fungal infections in liver transplant recipients. Transplantation 40: 347–353
Winston DJ, Gale RP, Meyer DV, Young LS (1979) Infectious complications of human bone marrow transplantation. Medicine 58: 1–31
Author information
Authors and Affiliations
About this article
Cite this article
Barkholt, L., Ericzon, B.G., Tollemar, J. et al. Infections in human liver recipients: different patterns early and late after transplantation. Transplant Int 6, 77–84 (1993). https://doi.org/10.1007/BF00336649
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00336649